← Open Payments lookup

REBECCA DEPALMA: Open Payments

NPI 1487277489 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$19,189 in 67 payments from 9 companies in 2025. Trend: 2023 $53 · 2024 $0 · 2025 $19,189

Consulting: $6,320Speaker / faculty: $6,000Food & beverage: $3,908Travel & lodging: $2,961
CompanyPaymentsAmount
ABBVIE INC.31$9,095
E.R. Squibb & Sons, L.L.C.19$8,671
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$389
Axsome Therapeutics, Inc.4$309
Vanda Pharmaceuticals Inc.2$249
Alkermes, Inc.2$150
Neurocrine BioSciences, Inc.2$148
Teva Pharmaceuticals USA, Inc.1$125
Takeda Pharmaceuticals U.S.A., Inc.2$54

Products named: VRAYLAR, COBENFY, CAPLYTA, Auvelity, FANAPT, ARISTADA, INGREZZA, UZEDY.

Industry payments across WA — which companies pay providers there.